Additionally, we speculate that the combination may modulate the tumour microenvironment, as the role of the JAK–STAT pathway in immune regulation suggests that its inhibition could activate immune responses against cancer cells or reduce immunosuppressive factors. The gene discussed is SOAT1; the disease is neoplasm.